{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:51:33Z","timestamp":1793393493709,"version":"4.5.0"},"reference-count":55,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,4]]},"DOI":"10.4269\/ajtmh.20-0255","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T07:01:25Z","timestamp":1596524485000},"page":"2129-2141","source":"Crossref","is-referenced-by-count":5,"title":["Stability of Oxytocin Preparations in Malawi and Rwanda: Stabilizing Effect of Chlorobutanol"],"prefix":"10.4269","volume":"103","author":[{"given":"Nhomsai","family":"Hagen","sequence":"first","affiliation":[{"name":"Pharmaceutical Institute, Eberhard Karls University T\u00fcbingen, T\u00fcbingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bizimana","sequence":"additional","affiliation":[{"name":"School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Claver","family":"Kayumba","sequence":"additional","affiliation":[{"name":"East African Community Regional Centre of Excellence for Vaccines, Immunizations and Health Supply Chain Management (EAC RCE-VIHSCM), University of Rwanda, Kigali, Rwanda;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Khuluza","sequence":"additional","affiliation":[{"name":"Pharmacy Department, College of Medicine, University of Malawi, Blantyre, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Heide","sequence":"additional","affiliation":[{"name":"Pharmaceutical Institute, Eberhard Karls University T\u00fcbingen, T\u00fcbingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","volume-title":"World Health Organization Model List of Essential Medicines 21st List 2019","year":"2019"},{"key":"b2","volume-title":"WHO Recommendations for the Prevention and Treatment of Post-Partum Haemorrhage","year":"2012"},{"key":"b3","volume-title":"Goal 3: Ensure Healthy Lives and Promote Well-Being for All at All Ages: United Nations","year":"2020"},{"key":"b4","volume-title":"Stability of Injectable Oxytocics in Tropical Climates: Results of Field Surveys and Simulation Studies on Ergometrine, Methylergometrine and Oxytocin","author":"Hogerzeil","year":"1993"},{"key":"b5","doi-asserted-by":"crossref","first-page":"e000431","DOI":"10.1136\/bmjopen-2011-000431","article-title":"Uterotonic drug quality: an assessment of the potency of injectable uterotonic drugs purchased by simulated clients in three districts in Ghana","volume":"2","author":"Stanton","year":"2012","journal-title":"BMJ Open"},{"key":"b6","article-title":"Post-market quality surveillance project","volume-title":"Maternal Health Care Products (Oxytocin and Ergometrine) on the Ghanaian Market","author":"Karikari-Boateng","year":"2013"},{"key":"b7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12884-014-0386-y","article-title":"Accessibility and potency of uterotonic drugs purchased by simulated clients in four districts in India","volume":"14","author":"Stanton","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"b8","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1111\/1471-0528.13998","article-title":"Quality of oxytocin available in low- and middle-income countries: a systematic review of the literature","volume":"123","author":"Torloni","year":"2016","journal-title":"BJOG"},{"key":"b9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12884-018-1671-y","article-title":"Quality medicines in maternal health: results of oxytocin, misoprostol, magnesium sulfate and calcium gluconate quality audits","volume":"18","author":"Anyakora","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"b10","doi-asserted-by":"crossref","first-page":"020415","DOI":"10.7189\/jogh.08.020415","article-title":"Quality of oxytocin ampoules available in health care facilities in the Democratic Republic of Congo: an exploratory study in five provinces","volume":"8","author":"Lambert","year":"2018","journal-title":"J Glob Health"},{"key":"b11","volume-title":"Survey of the Quality of Medicines Identified by the United Nations Commission on Life-Saving Commodities for Women and Children","year":"2015"},{"key":"b12","volume-title":"FDA Alert on the Use of Substandard Uterotonics in Hospitals and Clinics","year":"2017"},{"key":"b13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12884-020-2810-9","article-title":"Quality, availability and storage conditions of oxytocin and misoprostol in Malawi","volume":"20","author":"Hagen","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"b14","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s11095-009-9878-2","article-title":"Towards heat-stable oxytocin formulations: analysis of degradation kinetics and identification of degradation products","volume":"26","author":"Hawe","year":"2009","journal-title":"Pharm Res"},{"key":"b15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/bip.22260","article-title":"On the mechanism of degradation of oxytocin and its analogues in aqueous solution","volume":"100","author":"Wisniewski","year":"2013","journal-title":"Biopolymers"},{"key":"b16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/ajo.13046","article-title":"Ergometrine stability in postpartum haemorrhage kits: does temperature and light matter?","volume":"60","author":"Donnan","year":"2020","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"b17","doi-asserted-by":"crossref","first-page":"e029083","DOI":"10.1136\/bmjopen-2019-029083","article-title":"Temperature stability of oxytocin ampoules labelled for storage at 2\u00b0C\u20138\u00b0C and below 25\u00b0C: an observational assessment under controlled accelerated and temperature cycling conditions","volume":"9","author":"Nguyen","year":"2019","journal-title":"BMJ Open"},{"key":"b18","doi-asserted-by":"crossref","first-page":"010406","DOI":"10.7189\/jogh.05.010406","article-title":"Barriers and facilitators to the quality use of essential medicines for maternal health in low-resource countries: an Ishikawa framework","volume":"5","author":"Tran","year":"2015","journal-title":"J Glob Health"},{"key":"b19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/tmi.13043","article-title":"Equity dimensions of the availability and quality of reproductive, maternal and neonatal health services in Zambia","volume":"23","author":"Yan","year":"2018","journal-title":"Trop Med Int Health"},{"key":"b20","volume-title":"Business Case: Investing in Production of High-Quality Oxytocin for Low-Resource Settings","author":"Schocken","year":"2014"},{"key":"b21","volume-title":"Revisiting the Stability and Storage Specifications of Oxytocin Injection: A Literature Review","author":"Thakral","year":"2018"},{"key":"b22","volume-title":"WHO Expert Committee on Specifications for Pharmaceutical Preparations Fifty-Second Report","year":"2018"},{"key":"b23","volume-title":"WHO Prequalified Lists","year":"2019"},{"key":"b24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1057\/jphp.2013.53","article-title":"A quiet revolution in global public health: the World Health Organization\u2019s Prequalification of Medicines Programme","volume":"35","author":"\u2018t Hoen","year":"2014","journal-title":"J Public Health Policy"},{"key":"b25","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1365-3156.2008.02106.x","article-title":"Substandard medicines in resource-poor settings: a problem that can no longer be ignored","volume":"13","author":"Caudron","year":"2008","journal-title":"Trop Med Int Health"},{"key":"b26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12992-018-0421-2","article-title":"Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems","volume":"14","author":"Roth","year":"2018","journal-title":"Global Health"},{"key":"b27","volume-title":"Quality Guidelines","year":"2019"},{"key":"b28","volume-title":"Stability Testing of New Drug Substances and Products Q1A(R2)","year":"2003"},{"key":"b29","volume-title":"Annex 2: Stability Testing of Active Pharmaceutical Ingredients and Finished Pharmaceutical Products","year":"2009"},{"key":"b30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jpha.2013.09.003","article-title":"Development of forced degradation and stability indicating studies of drugs\u2014a review","volume":"4","author":"Blessy","year":"2014","journal-title":"J Pharm Anal"},{"key":"b31","volume-title":"Annex 7: Guidelines on the Conduct of Surveys of the Quality of Medicines","year":"2016"},{"key":"b32","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1371\/journal.pmed.1000052","article-title":"Guidelines for field surveys of the quality of medicines: a proposal","volume":"6","author":"Newton","year":"2009","journal-title":"PLoS Med"},{"key":"b33","volume-title":"Validation of Analytical Procedures: Text and Methodology Q2(R1)","year":"2005"},{"key":"b34","volume-title":"Benzyl Alcohol and Benzoic Acid Group Used as Excipients","year":"2017"},{"key":"b35","volume-title":"Prequalified Lists - Medicines\/Finished Pharmaceutical Products","year":"2019"},{"key":"b36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2013.01.051","article-title":"Aspartate buffer and divalent metal ions affect oxytocin in aqueous solution and protect it from degradation","volume":"444","author":"Avanti","year":"2013","journal-title":"Int J Pharm"},{"key":"b37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1208\/s12248-011-9268-7","article-title":"A new strategy to stabilize oxytocin in aqueous solutions: I. The effects of divalent metal ions and citrate buffer","volume":"13","author":"Avanti","year":"2011","journal-title":"AAPS J"},{"key":"b38","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/jps.23546","article-title":"The formation of oxytocin dimers is suppressed by the zinc-aspartate-oxytocin complex","volume":"102","author":"Avanti","year":"2013","journal-title":"J Pharm Sci"},{"key":"b39","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1021\/mp200622z","article-title":"A new strategy to stabilize oxytocin in aqueous solutions: II. Suppression of cysteine-mediated intermolecular reactions by a combination of divalent metal ions and citrate","volume":"9","author":"Avanti","year":"2012","journal-title":"Mol Pharm"},{"key":"b40","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/jps.3030480707","article-title":"The kinetics of degradation of chlorobutanol","volume":"48","author":"Nair","year":"1959","journal-title":"J Am Pharm Assoc"},{"key":"b41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1758-2652-13-35","article-title":"A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries","volume":"13","author":"Waning","year":"2010","journal-title":"J Int AIDS Soc"},{"key":"b42","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4269\/ajtmh.20-0184","article-title":"Substandard and falsified antibiotics and medicines against noncommunicable diseases in western Cameroon and northeastern democratic Republic of Congo","volume":"103","author":"Sch\u00e4fermann","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"b43","volume-title":"Oxytocin Quality-Evidence for Action","author":"Theunissen","year":"2018"},{"key":"b44","volume-title":"Buy Quality Oxytocin, Keep It Cold","year":"2018"},{"key":"b45","volume-title":"Manual for Procurement & Supply of Quality-Assured MNCH Commodities","year":"2019"},{"key":"b46","volume-title":"Appropriate Storage and Management of Oxytocin \u2013 A Key Commodity for Maternal Health","year":"2019"},{"key":"b47","doi-asserted-by":"crossref","first-page":"e0208367","DOI":"10.1371\/journal.pone.0208367","article-title":"Clinical experiences with the use of oxytocin injection by healthcare providers in a southwestern state of Nigeria: a cross-sectional study","volume":"14","author":"Ejekam","year":"2019","journal-title":"PLoS One"},{"key":"b48","doi-asserted-by":"crossref","first-page":"e0203810","DOI":"10.1371\/journal.pone.0203810","article-title":"Knowledge, perception and practice towards oxytocin stability and quality: a qualitative study of stakeholders in three resource-limited countries","volume":"13","author":"Oliver","year":"2018","journal-title":"PLoS One"},{"key":"b49","volume-title":"Temperature-Sensitive Health Products in the Expanded Programme on Immunization Cold Chain","year":"2015"},{"key":"b50","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s13346-017-0471-7","article-title":"Heat-stable sublingual oxytocin tablets as a potential needle-free approach for preventing postpartum hemorrhage in low-resource settings","volume":"8","author":"Zhu","year":"2018","journal-title":"Drug Deliv Transl Res"},{"key":"b51","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.aogh.2016.04.444","article-title":"The degradation of pharmaceutical oxytocin samples in Nepal and Vietnam","volume":"82","author":"Liu","year":"2016","journal-title":"Ann Glob Health"},{"key":"b52","first-page":"2564","article-title":"The MD simulation of the effect of chlorobutanol on the distribution of oxytocin in solution","volume":"27","author":"Xu","year":"2018","journal-title":"Chin J New Drugs"},{"key":"b53","first-page":"2238","article-title":"MD simulation of the substitutes of chlorobutanol in the oxytocin injection solution","volume":"27","author":"Xu","year":"2018","journal-title":"Chin J New Drugs"},{"key":"b54","doi-asserted-by":"crossref","first-page":"e3082","DOI":"10.1002\/psc.3082","article-title":"Development and stability of a heat-stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle-income countries","volume":"24","author":"Malm","year":"2018","journal-title":"J Pept Sci"},{"key":"b55","volume-title":"Press Release: Ferring Statement on Subsidised Pricing of Heat-Stable Carbetocin for the Prevention of Postpartum Haemorrhage in Low- and Lower-Middle Income Countries","year":"2019"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T17:42:20Z","timestamp":1611769340000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajtmh.org\/doi\/10.4269\/ajtmh.20-0255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11,4]]}},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.20-0255","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]}}}